Giovanni Di Costanzo

Statistics

Publications

Citations

310

H-Index

Active since

2001

Affiliations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico(Current)

Kindai University

Ehime University

Himeji Red Cross Hospital

Hamamatsu University School of Medicine

Giovanni Di Costanzo is an author at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico specializing in oncology, oncology pharmacotherapy, and hepatocellular carcinoma treatment.

Publications per year

2001–2023

Publications

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population

Andrea Casadei‐Gardini, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2022 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15

Towards intelligent decision support systems for emergency managers: the IDA approach

Adam Gadomski, Sandro Bologna, Giovanni Di Costanzo et al. · International Journal of Risk Assessment and Management · 2001 · 58 citations

Business, Knowledge Management, Systems Engineering +14

Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients

Mara Persano, Margherita Rimini, Toshifumi Tada et al. · European Journal of Cancer · 2023 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study

Massimo Iavarone, Federica Invernizzi, Tommy Ivanics et al. · Liver Transplantation · 2021 · 36 citations

Medicine, Oncology, Pharmacotherapy +17

Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study

Mara Persano, Margherita Rimini, Toshifumi Tada et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

1–5 of 5